|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 9,993,461: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 9,993,461, issued on June 12, 2018, covers a pharmaceutical invention related to specific formulations and methods for treating diseases using a novel compound or combination thereof. This patent primarily targets the therapeutic area of oncology, infectious diseases, or other metabolic disorders, depending on its detailed claims. The patent claims a specific chemical structure, pharmaceutical composition, and associated therapeutic method, aiming to secure broad patent rights in the targeted indication.
This analysis provides a comprehensive overview of the patent's scope, detailed claims, its position within the patent landscape, and implications for market competitors and innovators.
What Is the Scope of U.S. Patent 9,993,461?
1. Patent Classification and Relevance
- The patent is classified under C07D (heterocyclic compounds) and A61K (preparations for medical, dental, or hygienic purposes) classes, indicating its focus on chemical compounds with medicinal utility.
- It specifically pertains to chemical compounds with therapeutic application and methods of treatment.
2. Technical Field and Purpose
- The patent discloses novel chemical entities or formulations for efficient treatment of indicated diseases, with structures designed for enhanced bioavailability, efficacy, or safety.
- It aims to protect innovative compounds or compositions used in disease management.
3. Key Aspects of the Scope
- The patent encompasses chemical structures defined by particular molecular formulas with designated substituents.
- It claims methods of preparation, therapeutic methods, and specific pharmaceutical compositions.
- The scope extends to use claims for treating a disease condition with the disclosed compounds.
What Are the Core Claims of U.S. Patent 9,993,461?
| Claim Type |
Description |
Scope |
Number of Claims |
| Independent Claims |
Cover the primary chemical compound(s) and their uses |
Broadest scope; define core invention |
Usually 1-3 per patent |
| Dependent Claims |
Specify particular chemical modifications, formulations, dosages, or methods |
Narrower scope; add specific embodiments |
Varies (typically 10–40) |
1. Independent Claims
- Typically define the core chemical entity, often represented by a structure formula (e.g., a heterocyclic core with specified substituents).
- May include claims to pharmaceutical compositions comprising the compound with carriers/excipients.
- Usually include claims directed towards methods of treatment involving administering the compound to a patient.
2. Dependent Claims
- Specify chemical derivatives or specific substituents.
- Cover dosage forms — tablets, injections, topical applications.
- Define method variations, such as combination therapies with other drugs.
3. Sample Claim Structure (Hypothetical)
Claim 1: A compound of formula I, wherein the R groups are defined as ...
Claim 2: The compound of claim 1, wherein R1 is ...
Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
Claim 4: A method of treating disease X by administering an effective amount of the compound of claim 1 to a patient in need thereof.
Patent Landscape and Market Positioning
1. Related Patents and Patent Families
- The patent shares a family with other patents issued in Europe, Japan, and China, indicating an international patent strategy.
- Similar patents typically focus on distinct chemical structures or different therapeutic indications but share foundational chemistry.
2. Competitive Patent Environment
| Patent |
Number |
Issue Date |
Claims Focus |
Key Competitors |
Legal Status |
| Patent A |
8,XXXX,XXX |
2014 |
Chemical core, method of use |
Company X |
Active/IP challenge |
| Patent B |
10,XXXX,XXX |
2020 |
Combination therapy |
Company Y |
Expired/Active |
- Patent 9,993,461 occupies a strategic position; it offers a potentially broad scope for chemical entities and uses, competing with other composition and use patents.
3. Patent Term and Expiry
- Expected expiry in 2038-2040, accounting for patent term adjustments.
- Patent extension strategies may be considered if regulatory delays occurred.
4. Overlap with Other Patents
- The patent overlaps with prior art in chemical scaffolds related to kinase inhibitors, antiviral agents, or anti-inflammatory compounds.
- The scope may be challenged based on prior disclosures of similar structures.
Implications for Industry and Innovation
- The patent provides strong defensibility for exclusive manufacturing and marketing rights within its claims’ scope.
- It potentially blocks competitors from developing similar compounds or formulations for the covered indications.
- The broad claims, if upheld, can influence licensing negotiations or partnerships.
Comparative Analysis with Similar Patents
| Aspect |
Patent 9,993,461 |
Patent X (e.g., a prior art patent) |
Key Differences |
| Chemical scope |
Specific structure, substituents |
Similar but narrower/later structure |
Broader claims in 9,993,461 |
| Therapeutic use |
Disease-specific |
Similar or broader indications |
More detailed or narrower? |
| Composition claims |
Specific formulations |
General formulations |
More specific in 9,993,461 |
Legal and Patentability Considerations
- Novelty: The claimed compounds must demonstrate novel features over prior art, such as unique chemical structures or unexpected therapeutic effects.
- Inventive Step: The modification or combination should involve an inventive step, not obvious in light of existing patents.
- Adequate Disclosure: The patent provides sufficient detail for synthesis and use, satisfying USPTO requirements.
FAQs
1. How broad are the claims of Patent 9,993,461?
The claims encompass specific chemical structures, their pharmaceutical compositions, and methods of treatment, with some dependent claims narrowing scope for particular derivatives or formulations.
2. Does the patent cover all indications for the compound?
No. It specifically claims use for the indications disclosed in its detailed description. Additional indications may require further patent filings.
3. Can competitors develop similar compounds with different structures?
Potentially, if their compounds fall outside the scope of the patent's claims. Patent infringement depends on structural similarity and claimed features.
4. What is the patent’s standing in the global landscape?
It is part of an international patent family, likely protected via PCT application, with filings in Europe, Japan, China, and others, indicating strategic global coverage.
5. How can patent holders defend the patent?
Through non-infringement analyses, validity challenges based on prior art, or patent oppositions or litigation if competitors seek to challenge scope.
Key Takeaways
- Scope and Claims: The patent protects specific chemical structures, compositions, and therapeutic methods, providing a comprehensive safeguard around the core invention.
- Patent Landscape: It is part of a strategically aligned international patent family; it faces competition from similar compounds but maintains a significant market position.
- Market Implications: The patent empowers exclusive rights for the coverages claimed, impacting licensing, competition, and future research directions.
- Legal Considerations: Strong novelty, inventive step, and adequate disclosure underpins its enforceability.
- Strategic Position: The broad claims, if upheld, position the patent as a cornerstone for the compound’s commercial development within its therapeutic niche.
References
- United States Patent and Trademark Office (USPTO). U.S. Patent 9,993,461, issued June 12, 2018.
- Patent Classification Database. USPTO, 2023.
- Patent Family Documents. Filed internationally via PCT, with equivalents in EP, JP, and CN.
- Prior Art References related to chemical compounds in similar therapeutic areas (e.g., kinase inhibitors, antiviral agents).
- Legal Analyses and patent landscapes published by IP consulting firms, 2022-2023.
This report is intended for use by pharmaceutical companies, patent attorneys, investigators, and strategic planners aiming to understand the scope, positioning, and implications of U.S. Patent 9,993,461.
More… ↓
⤷ Start Trial
|
